Galderma’s 1% Ivermectin Cream expected later this year

Linda Stein Gold mentions in a video posted on Skin and Allergy News, referring to Galderma’s Ivermectin Cream ;

  • Phase 3 Clinical Trials have completed, and
  • FDA Approval is expected later this year (2014).

This is great new for those who 1) want to try an approved treatment for demodex mites and 2) may not be happy with their usage of Metrogel.

The clinical trial data suggests that after 14 days of treatment, the treatment was starting to work and after 4 weeks, 30% of patients were reported to be clear of the papules and pustules of rosacea.

Ivermectin is being described as safe and effective. Indeed this interview suggests that the Ivermectin cream may have less side effects that the vehicle that carries the active molecule!

Ivermectin is said to have 2 methods of action – anti inflammatory and its parasitic actions against demodex.

VIDEO: Ivermectin shows promise for treating papulopustular rosacea

Mar 23, 2014

Video recorded as part of the AAD Annual Meeting in Denver, CO.

Dr. Stein Gold was a clinical investigator for the trial and is a consultant for Galderma.

Related Articles

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Subscribe

If you enjoyed this article, subscribe now to receive more just like it.

Subscribe via RSS Feed Connect on Pinterest Connect on Google Plus

6 Reader Comments

  1. DaveM says:

    Excellent news, thanks for the update.

  2. Rob says:

    When in 2014 middle or end of year? Now would be nice!

  3. KC says:

    Okay now its late July…….???

  4. KC says:

    Okay, now late August………..when?

  5. AS says:

    I am also waiting for this. Any news.

  6. Eldon says:

    I only even receive this mail / thread now. Good news either way I guess.

Leave a Comment

Top